Showing results (1781-1790 of 1,821) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|April 17, 2025
RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancerZhengyu Zha, Chunxiao Liu, Meisi Yan, et al.
Acta Pharmacologica Sinica|January 24, 2024
Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulationChen Cheng, Chao Ren, Mu-Zi Li, et al.
Cancer Medicine|September 14, 2023
Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancerZi-Yao Jia, Yi-Di Zhu, Xiang-Song Wu, et al.
Cancer Discovery|February 20, 2021
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung CancerHongchen Cai, Su Kit Chew, Chuan Li, et al.
Nature Immunology|January 5, 2021
Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarminAshley J Russo, Swathy O Vasudevan, Santiago P Méndez-Huergo, et al.
Nutrients|September 9, 2023
Dietary Diversity Changes and Cognitive Frailty in Chinese Older Adults: A Prospective Community-Based Cohort StudyWen-Fang Zhong, Wei-Qi Song, Xiao-Meng Wang, et al.
Ecotoxicology and Environmental Safety|March 13, 2024
Long-term air pollutants exposure and respiratory mortality: A large prospective cohort studyZhi-Hao Li, Xiao-Meng Wang, Dan-Qing Liao, et al.
Ecotoxicology and Environmental Safety|September 24, 2023
Long-term air pollution exposure, habitual physical activity, and incident chronic kidney diseaseZhi-Hao Li, Wei-Qi Song, Cheng-Shen Qiu, et al.
Frontiers in Cell and Developmental Biology|May 3, 2021
Heterozygous Recurrent Mutations Inducing Dysfunction of ROR2 Gene in Patients With Short StatureBaoheng Gui, Chenxi Yu, Xiaoxin Li, et al.
Lancet (London, England)|January 11, 2025
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 studyMasatoshi Kudo, Zhenggang Ren, Yabing Guo, et al.
Pageof 183